drugset / Trial / NCT03594656

Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease

NCT03594656

Phase 3 Unknown 288 enrolled Xuanwu Hospital, Beijing
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Lingzhi(Ganoderma) is widely used in traditional Chinese medicine. Previous studies indicated that Lingzhi was safe, well tolorated, and improved symptoms as an add-on therapy to levodopa in early Parkinson's disease(PD) patients. Here the investigators design a multicenter, randomized, double-blind, placebo-controlled, delayed-start trial to evaluate the effects of Lingzhi on modifying disease progression in untreated PD patients.

Timeline

Start
2018-07-15
Primary completion
2021-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject LingZhi Traditional medicine (herbal / TCM) 0.8 g

Indications